Day: ខែ​សីហា 5, 2025

HONG KONG, Aug 5, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by China’s National Medical Products Administration (NMPA). This approval for production expansion will further boost capacity and increase product supply, enabling a more efficient response to the growing clinical demand in China and across Asia.NEFECON® is the first and only etiological treatment for IgA nephropathy (IgAN) to receive full approval in China, the United States, and Europe, serving as a foundational first-line therapy for patients with IgAN. Since its initial approval in China in November 2023, NEFECON® was subsequently included in the National Reimbursement Drug List (NRDL) in November 2024, and received full approval from the NMPA in May 2025, irrespective of proteinuria levels, benefiting most individuals living with IgAN.NEFECON® specifically modulates the mucosal immune system in…

HONG KONG, Aug 5, 2025 – (ACN Newswire via SeaPRwire.com) – On August 4, the China Robotics Industry ETF (159551) rose by 2.44%, as investor enthusiasm for the sector continues to surge. Humanoid robotics is transitioning from a phase of “technical breakthroughs” to one of “scenario implementation,” marking the start of a new acceleration cycle. With a series of industry catalysts unfolding, the robotics segment in the Hong Kong market is entering a structural upswing.Among the emerging opportunities, Shoucheng Holdings (0697.HK) stands out as a rare asset platform company with full-chain industrial deployment and real scenario execution capability.1. From Showroom to Deployment: Humanoid Robots Hit the Ground RunningAt the 2025 World Artificial Intelligence Conference (WAIC) held in late July, over 150 humanoid robots were demonstrated performing real-time dynamic tasks across industrial, service, and medical settings — a first in China. Unlike previous static displays, this year’s event showcased robots in …

NEW YORK, Aug 4, 2025 – (ACN Newswire via SeaPRwire.com) – Traveler Care, a breakthrough medical dispatch platform that brings urgent care directly to travelers in hotels, Airbnbs, and vacation rentals, has officially launched worldwide – offering travel insurance companies a high-impact solution to reduce avoidable emergency room and hospital claims.Traveler care traveler.care home pageA Concierge Alternative to the Emergency RoomTraveler Care connects travel insurers and their policyholders to a network of licensed, on-call providers who visit travelers in their accommodations – typically within 60-90 minutes. Conditions such as flu, food poisoning, dehydration, allergic reactions, UTIs, sprains, and wound care are treated on-site, eliminating the need for an ER visit.”In most cases, travelers just need a doctor – not a hospital admission,” said Eli Ofel, founder of Traveler Care. “We’ve built a scalable, insurer-ready solution that saves money and delivers a far better traveler experience.”Reduce Claims by…

Boca Raton, Florida–(ACN Newswire via SeaPRwire.com – August 4, 2025) – Atlas Lithium Corporation (NASDAQ: ATLX) (“Atlas Lithium” or “Company”), a leading lithium development company, is pleased to announce that SGS Canada Inc. (“SGS”) has completed the Definitive Feasibility Study (“DFS”) for the Company’s 100%-owned Neves Lithium Project (“Project”), a technical report prepared under the U.S. guidelines of Item 1300 of Regulation S-K (“Regulation S-K 1300”). This hard-rock Project is well-suited to being a low-cost open-pit mining operation, as its spodumene deposits are located relatively close to the surface. Located in the state of Minas Gerais, Brazil, the Project encompasses 4 of the 98 mineral rights for lithium owned by Atlas Lithium. As detailed in the DFS, the Neves Project is expected to deliver strong financial metrics with an internal rate of return (“IRR”) of 145%, payback in 11 months from the start of operations, and an after-tax net present value (“NPV”) of $539 million. Importantly, the DF…